Results 21 to 30 of about 13,762 (186)

Prognostic Performance of Bedside Lung Ultrasound Score (LUSS) and ROX Index in Hypoxemic Respiratory Failure Due to COVID-19 [PDF]

Diagnostics, 2023
Background: Noninvasive ventilation, mainly helmet CPAP, was widely used during the COVID-19 pandemic, even outside of intensive care units. Both the ROX index and the LUS score (LUSS) have been proposed as tools to predict negative outcomes in patients ...
Alice Nova, Emanuele Rezoagli, Nilde Eronia, Annalisa Benini, Andrea Scognamiglio, Giuseppe Foti, Giacomo Bellani   +6 more
doaj   +2 more sources

Prognostic Value of the ROX Index for Mortality in Chronic Obstructive Pulmonary Disease: A Retrospective Cohort Study Using the MIMIC-IV Database [PDF]

International Journal of COPD
Kai Liu,1,* Zehui Fu,1,* Dahang Luo,1,* Hua Xiao,2 Qiaobin Wu1 1Department of Emergency, the Affiliated Shunde Hospital of Jinan University, Foshan, Guangdong, People’s Republic of China; 2Department of Nephrology, the Affiliated ...
Liu K, Fu Z, Luo D, Xiao H, Wu Q
doaj   +2 more sources

Rox Index Dynamics According to High Flow Nasal Cannula Success in Intensive Care Unit Patients with COVID-19-Related Acute Respiratory Failure [PDF]

Balkan Medical Journal, 2023
Background: High-flow nasal cannula therapy has been shown to be useful in the treatment of patients with acute respiratory failure caused by severe acute respiratory syndrome-coronavirus disease-2. The ROX index can help predict the success of high-flow
Pervin Hancı, Ahmet Uysal, Beyza Yüksel, Volkan İnal   +3 more
doaj   +2 more sources

Impact of an ROX index-guided intubation strategy on mortality in patients receiving high-flow nasal cannula: a target trial emulation [PDF]

Journal of Intensive Care
Background The ROX index (the ratio of peripheral oxygen saturation to the fraction of inspired oxygen, divided by respiratory rate) has been validated to predict high-flow nasal cannula (HFNC) failure, but whether acting on ROX to guide the timing of ...
Ryohei Yamamoto, Takeshi Tohyama, Ahram Han, Norman Pedersen, Kerollos Nashat Wanis, Joseph Byers, Leo Anthony Celi   +6 more
doaj   +2 more sources

Performance of the ROX index in predicting high flow nasal cannula failure in COVID-19 patients: a systematic review and meta-analysis [PDF]

Critical Care, 2023
COVID-19 patients with acute hypoxemic respiratory failure (AHRF) benefit from high flow nasal cannula (HFNC) oxygen therapy. However, delays in initiating invasive ventilation after HFNC failure are associated with poorer outcomes.
Chun En Yau, Dawn Yi Xin Lee, Adithi Vasudevan, Ken Junyang Goh, Evelyn Wong, Andrew Fu Wah Ho, Daniel Yan Zheng Lim   +6 more
doaj   +2 more sources

Advantages and limitations of the ROX index. [PDF]

Pulmonology, 2022
Gallardo A, Zamarrón-López E, Deloya-Tomas E, Pérez-Nieto OR.   +3 more
europepmc   +5 more sources

Predicting Intubation in COVID-19 Patients by the ROX Index Method

Eurasian Journal of Emergency Medicine
Aim: To evaluate the diagnostic accuracy of the ROX index for predicting intubation in Coronavirus disease-2019 (COVID-19) patients receiving high nasal flow cannula (HNFC) and to underline the risk and association of intubation with pre-existing ...
Najia Tabassum, Sobia Hassan, Faraz Ahmed Baig   +2 more
doaj   +2 more sources

External validation of the HACOR score and ROX index for predicting treatment failure in patients with coronavirus disease 2019 pneumonia managed on high-flow nasal cannula therapy: a multicenter retrospective observational study in Japan [PDF]

Journal of Intensive Care
Background The HACOR score for predicting treatment failure includes vital signs and acid–base balance factors, whereas the ROX index only considers the respiratory rate, oxygen saturation, and fraction of inspired oxygen (FiO2).
Hiromu Okano, Ryohei Yamamoto, Yudai Iwasaki, Daisuke Irimada, Daisuke Konno, Taku Tanaka, Takatoshi Oishi, Hiroki Nawa, Akihiko Yano, Hiroaki Taniguchi, Masayuki Otawara, Ayaka Matsuoka, Masanori Yamauchi   +12 more
doaj   +2 more sources

Validity of the ROX index in predicting invasive mechanical ventilation requirement in pneumonia. [PDF]

BMJ Open Respir Res, 2022
Background The ROX index (Respiratory rate-OXygenation) has been described as a prediction tool to identify the need for invasive mechanical ventilation (IMV) in community-acquired pneumonia (CAP) with acute hypoxaemic respiratory failure treated with high-flow nasal cannula in order to avoid delay of a necessary ...
Reyes LF, Bastidas Goyes A, Tuta Quintero EA, Pedreros KD, Mantilla YF, Herrera M, Carmona GA, Saza LD, Bello LE, Muñoz CA, Chaves JC, Arias JC, Alcaraz PM, Hernández MD, Nonzoque AP, Trujillo N, Pineda AF, Montaño GS.   +17 more
europepmc   +6 more sources

Choice of respiratory therapy for COVID-19 patients with acute hypoxemic respiratory failure: a retrospective case series study [PDF]

PeerJ, 2023
Background In the treatment of acute hypoxemic respiratory failure (AHRF) due to coronavirus 2019 (COVID-19), physicians choose respiratory management ranging from low-flow oxygen therapy to more invasive methods, depending on the severity of the patient’
Kazuki Sudo, Teiji Sawa, Kohsuke Kushimoto, Ryogo Yoshii, Kento Yuasa, Keita Inoue, Mao Kinoshita, Masaki Yamasaki, Kunihiko Kooguchi   +8 more
doaj   +2 more sources